Bio-Rad Board Member Padou Passes Away; Invitrogen Loses Two VPs; Wellis Is New GenVault CEO; Nelles Tapped for R&D VP at XDx; and Others | GenomeWeb
NEW YORK (GenomeWeb News) - Bio-Rad reported last week that board member Philip Padou has died at the age of 72.
 
Padou joined Bio-Rad’s Board in 1980, and he was VP and CFO of Ozier Perry and Associates until his retirement in 1991.
 
David Schwartz, chairman of Bio-Rad’s board, said in a statement that Padou was “a dedicated and valuable member” of the board.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.